About VYNE Therapeutics Inc. - Common Stock (VYNE)
Vyne Therapeutics Inc is a biopharmaceutical company focused on developing innovative therapies to address unmet medical needs, particularly in the fields of dermatology and autoimmune diseases. The company is dedicated to creating unique drug formulations that leverage its proprietary technology platforms, aiming to improve patient outcomes and enhance the quality of life for individuals suffering from chronic conditions. Through its research and development efforts, Vyne seeks to bring forward novel treatments that can offer more effective and safer alternatives to existing therapies in the market. Read More
As of December 17, 2025, VYNE Therapeutics (NASDAQ: VYNE) stands at a pivotal juncture, having recently announced a definitive merger agreement with Yarrow Bioscience, Inc. This strategic move marks a significant transformation for the clinical-stage biopharmaceutical company, shifting its primary focus from its historical roots in immuno-inflammatory conditions, particularly dermatology, to the development of novel [...]
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of VYNE Therapeutics Inc. (NASDAQ: VYNE) and Yarrow Bioscience, Inc. is fair to VYNE shareholders. Upon completion of the proposed transaction, VYNE shareholders are expected to own approximately 3% of the combined company.
The company plans to seek a development and commercialization partner for repibresib and expects to provide an update on both repibresib and VYN202, which are currently under partial FDA clinical hold, in the coming weeks.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
As we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.
